Bailard Inc. Takes $802,000 Position in National Health Investors, Inc. $NHI

Bailard Inc. bought a new stake in National Health Investors, Inc. (NYSE:NHI) in the 4th quarter, according to its most recent 13F filing with the SEC. The firm bought 10,500 shares of the real estate investment trust’s stock, valued at approximately $802,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its stake in National Health Investors by 0.8% during the 3rd quarter. Vanguard Group Inc. now owns 6,498,414 shares of the real estate investment trust’s stock valued at $516,624,000 after purchasing an additional 52,474 shares during the last quarter. State Street Corp boosted its stake in National Health Investors by 5.0% during the 2nd quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust’s stock valued at $143,651,000 after purchasing an additional 95,812 shares during the last quarter. Principal Financial Group Inc. boosted its stake in National Health Investors by 1.9% during the 4th quarter. Principal Financial Group Inc. now owns 1,668,006 shares of the real estate investment trust’s stock valued at $127,386,000 after purchasing an additional 30,968 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in National Health Investors by 34.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,613,051 shares of the real estate investment trust’s stock valued at $128,238,000 after purchasing an additional 409,559 shares during the last quarter. Finally, Centersquare Investment Management LLC boosted its stake in National Health Investors by 21.8% during the 3rd quarter. Centersquare Investment Management LLC now owns 986,708 shares of the real estate investment trust’s stock valued at $78,443,000 after purchasing an additional 176,410 shares during the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

National Health Investors Price Performance

National Health Investors stock opened at $74.86 on Friday. National Health Investors, Inc. has a 52 week low of $68.80 and a 52 week high of $91.38. The company’s 50 day moving average price is $81.66 and its two-hundred day moving average price is $80.53. The company has a quick ratio of 8.20, a current ratio of 8.20 and a debt-to-equity ratio of 0.83. The stock has a market cap of $3.63 billion, a P/E ratio of 24.15, a P/E/G ratio of 4.31 and a beta of 0.55.

National Health Investors (NYSE:NHI) last posted its earnings results on Monday, May 4th. The real estate investment trust reported $0.82 EPS for the quarter, missing the consensus estimate of $1.21 by ($0.39). National Health Investors had a return on equity of 9.82% and a net margin of 36.86%.The firm had revenue of $115.13 million for the quarter, compared to the consensus estimate of $70.22 million. During the same period in the prior year, the business earned $1.15 EPS. National Health Investors’s quarterly revenue was up 28.9% compared to the same quarter last year. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, equities analysts predict that National Health Investors, Inc. will post 4.76 earnings per share for the current year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, August 7th. Shareholders of record on Tuesday, June 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.68 annualized dividend and a dividend yield of 4.9%. National Health Investors’s dividend payout ratio (DPR) is currently 118.71%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on NHI. Deutsche Bank Aktiengesellschaft downgraded National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 price target for the company. in a research note on Tuesday, January 20th. Truist Financial cut their price target on National Health Investors from $92.00 to $89.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Wells Fargo & Company cut their price target on National Health Investors from $86.00 to $84.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. National Bank Financial set a $85.00 price target on National Health Investors in a research note on Tuesday, January 20th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and set a $94.00 price target on shares of National Health Investors in a research note on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, National Health Investors currently has a consensus rating of “Moderate Buy” and an average target price of $87.50.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.